Literature DB >> 28637187

Identification of pulmonary vein reconnection gaps with high-density mapping in redo atrial fibrillation ablation procedures.

Ignacio García-Bolao1, Gabriel Ballesteros1, Pablo Ramos1, Diego Menéndez1, Ane Erkiaga2, Renzo Neglia1, Marta Jiménez Martín1, Enrique Vives-Rodríguez1.   

Abstract

Aims: Maps obtained by means of electroanatomic high-density mapping (HDM) systems have shown their use in the identification of conduction gaps in experimental atrial linear lesion models. The objective of this study was to assess the use of HDM in the recognition of reconnection gaps in pulmonary veins (PV) in redo atrial fibrillation (AF) ablation procedures. Methods and results: One hundred and eight patients were included in a non-randomized study that assessed the recognition of reconnection gaps in PV by means of HDM compared to a control group that received conventional non-fluoroscopic guidance with a circular multipolar catheter (CMC). Among the HDM group, adequate recognition of reconnection gaps was obtained in 60.99% of the reconnected PVs (86 of 141), a figure significantly higher than that achieved with analysis of CMC recorded signals (39.66%, 48 of 121; P = 0.001). The number of applications and total radiofrequency time were also significantly lower in the HDM group (12.46 ± 6.1 vs. 15.63 ± 7.7 and 7.61 ± 3 vs. 9.29 ± 5; P = 0.02, and P = 0.03, respectively). At the 6-month follow-up, no statistically significant differences were found in recurrence of AF or any other atrial tachycardia between the HDM group (8 patients, 14.8%) and the control group in (16 patients, 29.6%; P = 0.104).
Conclusion: An analysis of the high-density activation maps allows greater precision in the identification of reconnection gaps in PV, which results in lower radiofrequency time for the new isolation.

Entities:  

Mesh:

Year:  2018        PMID: 28637187     DOI: 10.1093/europace/eux184

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

Review 1.  [High-resolution 3D mapping : Opportunities and limitations of the Rhythmia™ mapping system].

Authors:  Christian Ellermann; Gerrit Frommeyer; Lars Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-07-17

2.  Advanced mapping strategies for ablation therapy in adults with congenital heart disease.

Authors:  Fares-Alexander Alken; Niklas Klatt; Paula Muenkler; Katharina Scherschel; Christiane Jungen; Ruken Oezge Akbulak; Ann-Kathrin Kahle; Melanie Gunawardene; Mario Jularic; Leon Dinshaw; Jens Hartmann; Christian Eickholt; Stephan Willems; Fridrike Stute; Goetz Mueller; Stefan Blankenberg; Carsten Rickers; Christoph Sinning; Elvin Zengin-Sahm; Christian Meyer
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

3.  Acute safety, effectiveness, and real-world clinical usage of ultra-high density mapping for ablation of cardiac arrhythmias: results of the TRUE HD study.

Authors:  Gerhard Hindricks; Stanislav Weiner; Tom McElderry; Pierre Jaïs; William Maddox; Jose Ignacio Garcia-Bolao; Sang Yong Ji; Frederic Sacher; Stephan Willems; John Mounsey; Philippe Maury; Andreas Bollmann; Elizabeth Duffy; Giovanni Raciti; Roderick Tung; Tom Wong
Journal:  Europace       Date:  2019-04-01       Impact factor: 5.214

4.  Comparison of ablation outcomes of the second ablation procedure for recurrent atrial fibrillation using an ultra-high-resolution mapping system and conventional mappings system.

Authors:  Masaharu Masuda; Mitsutoshi Asai; Osamu Iida; Shin Okamoto; Takayuki Ishihara; Kiyonori Nanto; Takashi Kanda; Takuya Tsujimura; Yasuhiro Matsuda; Shota Okuno; Aki Tsuji; Toshiaki Mano
Journal:  Clin Cardiol       Date:  2019-08-12       Impact factor: 2.882

5.  Improved procedural workflow for catheter ablation of paroxysmal AF with high-density mapping system and advanced technology: Rationale and study design of a multicenter international study.

Authors:  Francesco Solimene; Giuseppe Stabile; Pablo Ramos; Luca Segreti; Filippo Maria Cauti; Valerio De Sanctis; Ruggero Maggio; Javier Ramos-Maqueda; Lluis Mont; Vincenzo Schillaci; Maurizio Malacrida; Ignacio Garcia-Bolao
Journal:  Clin Cardiol       Date:  2022-04-21       Impact factor: 3.287

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.